pubmed-article:16061129 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:16061129 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:16061129 | lifeskim:mentions | umls-concept:C0151636 | lld:lifeskim |
pubmed-article:16061129 | lifeskim:mentions | umls-concept:C0025887 | lld:lifeskim |
pubmed-article:16061129 | lifeskim:mentions | umls-concept:C0429028 | lld:lifeskim |
pubmed-article:16061129 | lifeskim:mentions | umls-concept:C0205307 | lld:lifeskim |
pubmed-article:16061129 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
pubmed-article:16061129 | lifeskim:mentions | umls-concept:C0301630 | lld:lifeskim |
pubmed-article:16061129 | lifeskim:mentions | umls-concept:C1708528 | lld:lifeskim |
pubmed-article:16061129 | lifeskim:mentions | umls-concept:C0332624 | lld:lifeskim |
pubmed-article:16061129 | lifeskim:mentions | umls-concept:C0522497 | lld:lifeskim |
pubmed-article:16061129 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:16061129 | pubmed:dateCreated | 2005-8-2 | lld:pubmed |
pubmed-article:16061129 | pubmed:abstractText | Antiarrhythmic potential of mexiletine in patients with congenital and acquired long-QT syndrome (LQTS) has been attributed to a reduction of transmural dispersion of repolarization (TDR). A similar mechanism could be involved in the antiarrhythmic activity of the drug in patients with normal QT intervals, but the issue remains to be investigated. | lld:pubmed |
pubmed-article:16061129 | pubmed:language | eng | lld:pubmed |
pubmed-article:16061129 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16061129 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:16061129 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16061129 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:16061129 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:16061129 | pubmed:month | Aug | lld:pubmed |
pubmed-article:16061129 | pubmed:issn | 0167-5273 | lld:pubmed |
pubmed-article:16061129 | pubmed:author | pubmed-author:KodamaItsuoI | lld:pubmed |
pubmed-article:16061129 | pubmed:author | pubmed-author:SawadaKenK | lld:pubmed |
pubmed-article:16061129 | pubmed:author | pubmed-author:TakeuchiHiros... | lld:pubmed |
pubmed-article:16061129 | pubmed:author | pubmed-author:HishidaHitosh... | lld:pubmed |
pubmed-article:16061129 | pubmed:author | pubmed-author:YasuiKenjiK | lld:pubmed |
pubmed-article:16061129 | pubmed:author | pubmed-author:WatanabeEiich... | lld:pubmed |
pubmed-article:16061129 | pubmed:author | pubmed-author:YamauchiMasak... | lld:pubmed |
pubmed-article:16061129 | pubmed:author | pubmed-author:TerasawaToshi... | lld:pubmed |
pubmed-article:16061129 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:16061129 | pubmed:day | 3 | lld:pubmed |
pubmed-article:16061129 | pubmed:volume | 103 | lld:pubmed |
pubmed-article:16061129 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:16061129 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:16061129 | pubmed:pagination | 92-7 | lld:pubmed |
pubmed-article:16061129 | pubmed:dateRevised | 2010-3-29 | lld:pubmed |
pubmed-article:16061129 | pubmed:meshHeading | pubmed-meshheading:16061129... | lld:pubmed |
pubmed-article:16061129 | pubmed:meshHeading | pubmed-meshheading:16061129... | lld:pubmed |
pubmed-article:16061129 | pubmed:meshHeading | pubmed-meshheading:16061129... | lld:pubmed |
pubmed-article:16061129 | pubmed:meshHeading | pubmed-meshheading:16061129... | lld:pubmed |
pubmed-article:16061129 | pubmed:meshHeading | pubmed-meshheading:16061129... | lld:pubmed |
pubmed-article:16061129 | pubmed:meshHeading | pubmed-meshheading:16061129... | lld:pubmed |
pubmed-article:16061129 | pubmed:meshHeading | pubmed-meshheading:16061129... | lld:pubmed |
pubmed-article:16061129 | pubmed:meshHeading | pubmed-meshheading:16061129... | lld:pubmed |
pubmed-article:16061129 | pubmed:meshHeading | pubmed-meshheading:16061129... | lld:pubmed |
pubmed-article:16061129 | pubmed:meshHeading | pubmed-meshheading:16061129... | lld:pubmed |
pubmed-article:16061129 | pubmed:meshHeading | pubmed-meshheading:16061129... | lld:pubmed |
pubmed-article:16061129 | pubmed:meshHeading | pubmed-meshheading:16061129... | lld:pubmed |
pubmed-article:16061129 | pubmed:meshHeading | pubmed-meshheading:16061129... | lld:pubmed |
pubmed-article:16061129 | pubmed:meshHeading | pubmed-meshheading:16061129... | lld:pubmed |
pubmed-article:16061129 | pubmed:meshHeading | pubmed-meshheading:16061129... | lld:pubmed |
pubmed-article:16061129 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:16061129 | pubmed:articleTitle | Prevention of ventricular extrasystole by mexiletine in patients with normal QT intervals is associated with a reduction of transmural dispersion of repolarization. | lld:pubmed |
pubmed-article:16061129 | pubmed:affiliation | Department of Cardiology, Gifu Shakai Hoken Hospital, Kani, Japan. | lld:pubmed |
pubmed-article:16061129 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:16061129 | pubmed:publicationType | Comparative Study | lld:pubmed |